Clinical Trial Details
Braintumor Website

[Information provided by: ClinicalTrials.gov, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT01599052 : Social Cognition in Children Treated for a Brain Tumour
PhaseN/A
AgesMin: 5 Years Max: 12 Years
Eligibility
Inclusion Criteria:

- Aged 5-13 years at first assessment (All groups)

- Newly diagnosed brain tumour patients that have not yet received adjuvant therapy (BT
patients only)

- Stable medical condition (BT and CF patients only)

Exclusion Criteria:

- Diagnosed with a disorder of the autistic spectrum (Autism, Asperger's Syndrome or
Pervasive Developmental Disorder not otherwise specified - All groups) that does not
seem to be related to the tumour (BT patients only).

- History of other brain disease or neurological condition interfering with normal
development (All groups).

- No native Dutch speaker (All groups)

- Severe sensory handicaps and/or behavioural problems interfering with reliable
neuropsychological assessment (All groups)

- IQ below 70 (All groups)

- Poor prognosis and life expectancy less than 1 year (BT patients only)
LinksPermanent Link to THIS page: https://virtualtrials.com/nct/display1trial.cfm?nct=NCT01599052      |      Link to official Clinicaltrials.gov listing
Locations



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740